Clinical Trial Update: Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy

View source ↗

Summary

A University of Alabama at Birmingham trial is recruiting to evaluate a human induced pluripotent stem cell-based therapy aimed at repairing vasodegenerative ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Retinopathy

Drugs mentioned

• iPSC-based therapy for vasodegenerative vessels (induced pluripotent stem cells)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Diabetes Complications, Diabetic Retinopathy | Status: RECRUITING